CT thoughts
The "trial" as described in the release appears to be more of a Pharnacokinetic / Pharmacodydnamic initiative. Its not looking at efficacy but rather rate of absorption, bioavailability and distribution. This should not require many "patients", take particularly long or be that expensive. How fast, how much and where does the active ingredient preferably end up. For example, a THC only strip vs a CBD only strip vs a THC/CBD combo strip would be distributed differently (target tissue) in the body.
This "trail" is as much about seperating the nanoparticle technology and LDS from the pack. The look alikes, the incorrectly described and the less reproducable formats. The pretenders.
My thought is that in addition to validating the superiority of the nanoparticle delivery method what this also sets up is CannaStrips actually being viewed as a drug (yes I know) in the sense that you can know exactly how much active ingredient is being delivered and to what tissues. I suspect that this initiative alone will bring interested third-parites (pehaps pharmas) out of the woods. It can now be credibly studied, assayed and trialed down the road. Very cool.
Key thing though is any user, recreational or medical, can know with certainty what they are getting in terms of active ingredient. Even if you know the amout of active incredient in the dose you can't do that reproducably unless the delivery system allows a more direct absorption into the bloodstream avoiding poor absorption and by passing the liver.
Dr. Sanderson and the nanoparticle delivery method are the reasons why I own some of the stock. They are on the right track. IMHO